GMP Life Science ApS: Financial statements 2025
CVR: 44388189
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
GMP Life Science ApS (CVR 44388189) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 6,506,063 and a net result of DKK 1,031,202. Equity in the 2025 report amounted to DKK 1,635,005. The solvency ratio was 51.3%.
- Gross Profit
- DKK 6,506,063
- Profit/Loss
- DKK 1,031,202
- Equity
- DKK 1,635,005
- Total Assets
- DKK 3,188,022
- Employees
- 0
Official annual report
How creditworthy is GMP Life Science ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of December 11, 2025, Sønderup Godkendt Revisionsaktieselskab has been appointed auditor of GMP Life Science ApS.
As of December 11, 2025, Revisionsfirmaet Tom Sønderup I/S has stepped down as auditor of GMP Life Science ApS.
As of November 28, 2025, Frank Winther-Hinge is registered as adm. dir. of GMP Life Science ApS.
As of November 28, 2025, Lars Bo Grønborg has stepped down as director of GMP Life Science ApS.
GMP Life Science ApS has published its interim report for the period October 25, 2023 to December 31, 2024.
About GMP Life Science ApS
GMP Life Science ApS is a Danish company of the type Anpartsselskab based in Glostrup, founded in 2023. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Frank Winther-Hinge. The company is owned by GMP Consulting Group ApS. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK 6,506,063 and a net result of DKK 1,031,202. Equity in the 2025 report amounted to DKK 1,635,005.